1 Davis ME. Glioblastoma: Overview of Disease and Treatment. Clin J Oncol Nurs. 2016;20(5 Suppl):S2-S8. doi:10.1188/16.CJON.S1.2-8
2 Ou A, Yung WKA, Majd N. Molecular Mechanisms of Treatment Resistance in Glioblastoma. Int J Mol Sci. 2020;22(1):351. Published 2020 Dec 31. doi:10.3390/ijms22010351
3 Poon, M.T.C., Sudlow, C.L.M., Figueroa, J.D. et al. Longer-term (≥ 2 years) survival in patients with glioblastoma in population-based studies pre- and post-2005: a systematic review and meta-analysis. Sci Rep 10, 11622 (2020). https://doi.org/10.1038/s41598-020-68011-4
4 Tan, AC, Ashley, DM, López, GY, Malinzak, M, Friedman, HS, Khasraw, M. Management of glioblastoma: State of the art and future directions. CA Cancer J Clin. 2020: 70: 299– 312. https://doi.org/10.3322/caac.21613
5 The All-Party Parliamentary Group on Brain Tumours. (2018). Brain tumours – a cost too much to bear? Report of the Inquiry into the economic and social impacts of brain tumours. www.braintumourresearch.org
6 Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005 Mar 10;352(10):987-96. doi: 10.1056/NEJMoa043330. PMID: 15758009.
7 Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009 May;10(5):459-66. doi: 10.1016/S1470-2045(09)70025-7. Epub 2009 Mar 9. PMID: 19269895.
8 Tamimi AF, Juweid M. Epidemiology and Outcome of Glioblastoma. In: De Vleeschouwer S, editor. Glioblastoma [Internet]. Brisbane (AU): Codon Publications; 2017 Sep 27. Chapter 8. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470003/ doi: 10.15586/codon.glioblastoma.2017.ch8
9 Information Sheet 4: High-Grade Glioma brain tumours and treatment options. (2014.). Retrieved August 26, 2021, from www.braintumouruk.org.uk. Accessed at: https://www.nice.org.uk/guidance/ta121/documents/glioma-overview2